Melanotan I Dosage Guide
Complete guide to Melanotan I dosing protocols, administration methods, and safety considerations for research purposes.
Research Use Only: The dosage information provided is for educational and research purposes. Peptides are not approved by the FDA for human use. Always consult with a healthcare professional.
Recommended Dosage
Clinical: 16mg implant every 2 months. Research protocols for tanning typically use 0.5-1mg daily for loading, then maintenance dosing.
Administration Method
FDA-approved form is a subcutaneous implant. Research use involves subcutaneous injection. Often combined with minimal UV exposure to enhance results.
Side Effects to Monitor
Nausea (especially initially), facial flushing, fatigue, headache, and darkening of existing moles or freckles.
Safety Considerations & Risks
May darken existing moles making melanoma detection difficult. Not recommended for those with history of melanoma. Long-term effects on melanocytes not fully characterized.